BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21539687)

  • 21. Medication adherence skills training for middle-aged and elderly adults with bipolar disorder: development and pilot study.
    Depp CA; Lebowitz BD; Patterson TL; Lacro JP; Jeste DV
    Bipolar Disord; 2007 Sep; 9(6):636-45. PubMed ID: 17845279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physicians' ability to predict patients' adherence to antihypertensive medication in primary care.
    Zeller A; Taegtmeyer A; Martina B; Battegay E; Tschudi P
    Hypertens Res; 2008 Sep; 31(9):1765-71. PubMed ID: 18971555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
    Maneesakorn S; Robson D; Gournay K; Gray R
    J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry (e-STAR) in six countries.
    Peuskens J; Olivares JM; Pecenak J; Tuma I; Bij de Weg H; Eriksson L; Resseler S; Akhras K; Jacobs A
    Curr Med Res Opin; 2010 Mar; 26(3):501-9. PubMed ID: 20014981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methodology of a pilot study to improve the quality of medication use in older adults: Enhancing Quality in Psychiatry Using Pharmacists (EQUIPP).
    Roth MT; Watson LC; Esserman DA; Ivey JL; Hansen R; Lewis CL; Weinberger M
    Am J Geriatr Pharmacother; 2009 Dec; 7(6):362-72. PubMed ID: 20129257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medication adherence and significant others' support of consumers with schizophrenia in Australia.
    McCann TV; Lu S
    Nurs Health Sci; 2009 Sep; 11(3):228-34. PubMed ID: 19689630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
    Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP;
    J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders.
    Lee MS; Lee HY; Kang SG; Yang J; Ahn H; Rhee M; Ko YH; Joe SH; Jung IK; Kim SH
    J Affect Disord; 2010 Jun; 123(1-3):216-21. PubMed ID: 19914719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome.
    Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa A; Goldfinger SM
    J Clin Psychiatry; 2009 Oct; 70(10):1397-406. PubMed ID: 19906343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What community living problems do persons with schizophrenia report during periods of stability?
    Beebe LH
    Perspect Psychiatr Care; 2010 Jan; 46(1):48-55. PubMed ID: 20051078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication.
    Gray R; Rofail D; Allen J; Newey T
    J Adv Nurs; 2005 Oct; 52(1):31-7. PubMed ID: 16149978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence to multiple, prescribed medications in diabetic kidney disease: A qualitative study of consumers' and health professionals' perspectives.
    Williams AF; Manias E; Walker R
    Int J Nurs Stud; 2008 Dec; 45(12):1742-56. PubMed ID: 18701103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. At what age do children start taking daily asthma medicines on their own?
    Orrell-Valente JK; Jarlsberg LG; Hill LG; Cabana MD
    Pediatrics; 2008 Dec; 122(6):e1186-92. PubMed ID: 19047221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why and how people decide to stop taking prescribed psychiatric medication: exploring the subjective process of choice.
    Roe D; Goldblatt H; Baloush-Klienman V; Swarbrick M; Davidson L
    Psychiatr Rehabil J; 2009; 33(1):38-46. PubMed ID: 19592378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Qualitative inquiry into motivators for maintaining medication adherence among Taiwanese with schizophrenia.
    Chang YT; Tao SG; Lu CL
    Int J Ment Health Nurs; 2013 Jun; 22(3):272-8. PubMed ID: 22882876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Patient modified medication: how do schizophrenic patients manage their neuroleptics?].
    Hornung WP; Buchkremer G; Redbrake M; Klingberg S
    Nervenarzt; 1993 Jul; 64(7):434-9. PubMed ID: 8103569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma.
    Bender BG; Apter A; Bogen DK; Dickinson P; Fisher L; Wamboldt FS; Westfall JM
    J Am Board Fam Med; 2010; 23(2):159-65. PubMed ID: 20207925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of antipsychotic medication taking in people with schizophrenia.
    McCann TV; Deans C; Clark E; Lu S
    Int J Ment Health Nurs; 2008 Dec; 17(6):428-38. PubMed ID: 19128290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.